Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue.
Pancreatology(2017)
摘要
Serum and plasma were found to be good materials for detecting cancer-specific DNA in the peripheral blood and the presence of KRAS mutations in blood-derived DNA may be used as a prognostic biomarker for patients with pancreatic cancer.
更多查看译文
关键词
KRAS,Droplet digital polymerase chain reaction,Liquid biopsy,Pancreatic cancer
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要